| Ytd | -13.51% | |
| 1y | -4.73% |
| Open | 43.82 | Prev Close | 43.73 | Low | 42.84 | High | 43.82 | Mkt Cap | 2.50B |
| Vol | 72.41K | Avg Vol | 851.67K | EPS | -1.92 | P/E | N/A | Forward P/E | 9.80 |
| Beta | 0.56 | Short Ratio | 4.42 | Inst. Own | 106.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 46.74 | 200-d Avg | 48.53 | 1yr Est | 61.75 |
SUPN News
ROCKVILLE, Md., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Professional snowboarder, Chloe Kim, is partnering
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Supernus Pharmaceuticals
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale
BlackRock Inc. purchased a new position in Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the unde
Investors need to pay close attention to SUPN stock based on the movements in the options market lat
Supernus Pharmaceuticals (NASDAQ:SUPN) held its second-quarter earnings conference call on Tuesday.
The most oversold health care stocks present a buying opportunity. RSI indicator compares stock stre
Supernus and Indivior agree to merge in an all-stock deal, targeting $2.2 billion in revenue and $12
Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.53 per share which beat the
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday'
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today
Cantor Fitzgerald analyst Kristen Kluska maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a
Supernus Pharmaceuticals (NASDAQ:SUPN) affirms FY2026 sales outlook from $840.000 million-$870.000 m
Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly losses of $(0.04) per share which missed t
Supernus Pharmaceuticals (NASDAQ:SUPN) sees FY2026 sales of $840.000 million-$870.000 million vs $86
Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly losses of $(0.07) per share which beat the
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its
On Tuesday, 647 companies set new 52-week lows.
On Monday, 369 companies set new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
During Tuesday's session, 275 companies made new 52-week lows.
Friday's session saw 169 companies set new 52-week lows.
Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for
During Thursday's session, 108 stocks hit new 52-week highs.
Most FDA decisions scheduled for September yielded positive results, but there were stray disappoint
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing hi
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report qu
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earning